Supportive, Psychosocial and Palliative Care Research Department, Cabrini Health, 646 High Street, Prahran, Melbourne, VIC, Australia.
School of Medicine, University of Notre Dame Australia , NSW, Australia.
Support Care Cancer. 2022 Sep;30(9):7387-7396. doi: 10.1007/s00520-022-07163-7. Epub 2022 May 25.
The objective of this study was to expand the international psychometric validation of the Cancer Communication Assessment Tool for Patients and Families (CCAT-PF) within a sample of Australian cancer patients.
Survey data from 181 cancer patient-caregiver dyads ≥ 18 years of age with solid or haematological cancers were analysed (85.4% response rate). Spearman's rho was used to examine the correlation between CCAT-P and CCAT-F scores and weighted kappa the agreement between them. Exploratory factor analysis using scree plot and Kaiser-Guttman criteria was conducted to evaluate the scale structure. Cronbach's α and Pearson correlation coefficients were used to measure internal consistency and concurrent validity respectively.
Mean scores were the following: CCAT-P 46.2 (9.8), CCAT-F 45.7 (9.4), and CCAT-PF 24.1 (8.0). We confirmed the poor concordance between patient and caregiver reporting of items in the CCAT-PF, with all but two items having weighted kappa values < 0.20 and Spearman's rho < 0.19. We derived a three-factor solution, disclosure, limitation of treatment, and treatment decision making, with reliability ranging from Cronbach's α = 0.43-0.53. The CCAT-P and CCAT-F showed strong correlations with preparation for decision-making (CCAT-P: r = 0.0.92; CCATF: r = 0.0.93) but were weakly associated with patient/caregiver distress related with having difficult conversations on future care planning.
Preliminary validation of the CCAT-PF in the Australian setting has shown some similar psychometric properties to previously published studies, further supporting its potential utility as a tool to assess patient-caregiver dyadic communication.
ACTRN12620001035910 12/10/2020 retrospectively registered.
本研究旨在对澳大利亚癌症患者样本中患者和家属癌症沟通评估工具(CCAT-PF)进行国际心理计量学验证。
对 181 对年龄≥18 岁的实体瘤或血液恶性肿瘤患者-照顾者进行调查(85.4%的响应率)。采用斯皮尔曼等级相关系数分析 CCAT-P 和 CCAT-F 评分之间的相关性,加权 kappa 分析两者之间的一致性。采用折线图和 Kaiser-Guttman 标准进行探索性因子分析,评估量表结构。采用克朗巴赫's α 和皮尔逊相关系数分别测量内部一致性和同时效度。
平均得分为:CCAT-P 46.2(9.8),CCAT-F 45.7(9.4),CCAT-PF 24.1(8.0)。我们证实了患者和照顾者报告 CCAT-PF 项目的一致性较差,除了两项外,所有项目的加权 kappa 值均<0.20,斯皮尔曼等级相关系数均<0.19。我们得出了三个因素的解决方案,即披露、治疗限制和治疗决策,可靠性从 Cronbach's α=0.43-0.53。CCAT-P 和 CCAT-F 与决策准备具有较强的相关性(CCAT-P:r=0.0.92;CCATF:r=0.0.93),但与与未来护理计划的艰难对话相关的患者/照顾者痛苦的相关性较弱。
在澳大利亚环境中对 CCAT-PF 的初步验证显示出与先前发表的研究相似的心理计量学特性,进一步支持其作为评估患者-照顾者二元沟通的工具的潜在效用。
ACTRN12620001035910 于 2020 年 10 月 12 日进行了回顾性注册。